METABOLISM-CLINICAL AND EXPERIMENTAL

Scope & Guideline

Uncovering Breakthroughs in Metabolic Disease Research

Introduction

Delve into the academic richness of METABOLISM-CLINICAL AND EXPERIMENTAL with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0026-0495
PublisherW B SAUNDERS CO-ELSEVIER INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1952 to 2024
AbbreviationMETABOLISM / Metab.-Clin. Exp.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899

Aims and Scopes

The journal 'Metabolism-Clinical and Experimental' primarily focuses on the interplay between metabolic processes and their clinical implications, often examining the underlying mechanisms of metabolic disorders and their management. It serves as a platform for disseminating research related to metabolic diseases and their associations with various physiological and pathological conditions.
  1. Metabolic Disorders and Diseases:
    The journal emphasizes research on various metabolic disorders, including diabetes, obesity, metabolic syndrome, and non-alcoholic fatty liver disease (NAFLD), exploring their pathophysiology, diagnosis, and treatment strategies.
  2. Clinical Implications of Metabolism:
    Publications often focus on the clinical implications of metabolic research, including how metabolic dysfunction impacts overall health and contributes to comorbidities such as cardiovascular diseases and renal impairment.
  3. Innovative Therapeutics and Pharmacotherapy:
    The journal highlights advancements in pharmacotherapy for metabolic disorders, including the efficacy of new drugs, combination therapies, and the role of lifestyle interventions in managing these conditions.
  4. Biomarkers and Diagnostic Tools:
    Research on biomarkers for diagnosing metabolic disorders and assessing disease progression is a core area, with studies exploring the use of novel diagnostic tools and technologies.
  5. Translational Research and Clinical Trials:
    The journal features studies that bridge basic metabolic research with clinical applications, focusing on translational research findings and results from clinical trials.
  6. Genetic and Epigenetic Influences:
    Studies examining genetic factors influencing metabolic diseases, as well as epigenetic modifications and their implications for disease progression, are regularly included.
  7. Systematic Reviews and Meta-analyses:
    The journal publishes systematic reviews and meta-analyses that synthesize existing research, providing comprehensive insights into the state of knowledge regarding metabolic disorders.
The journal 'Metabolism-Clinical and Experimental' has observed a shift towards several trending and emerging research themes that reflect the current priorities and advancements in the field of metabolism and its clinical applications. These themes highlight the integration of novel technologies and interdisciplinary approaches to address complex metabolic issues.
  1. Omics Technologies in Metabolism Research:
    There is an increasing focus on the application of omics technologies (genomics, proteomics, metabolomics) to understand metabolic disorders at a systems level, enabling personalized medicine approaches.
  2. Role of Gut Microbiome in Metabolism:
    Research exploring the relationship between gut microbiota and metabolic health is gaining traction, emphasizing the gut's role in influencing metabolic outcomes and potential therapeutic strategies.
  3. Mental Health and Metabolic Disorders:
    Emerging studies are investigating the interplay between mental health conditions (such as depression and anxiety) and metabolic disorders, highlighting the psychosocial aspects of metabolic diseases.
  4. Digital Health and Remote Monitoring:
    The incorporation of digital health technologies for monitoring and managing metabolic diseases, including continuous glucose monitoring and telemedicine, is becoming a prominent research area.
  5. Interdisciplinary Approaches to Metabolic Health:
    There is a trend towards interdisciplinary research that combines insights from nutrition, exercise science, pharmacology, and behavioral health to develop comprehensive treatment strategies for metabolic disorders.
  6. Focus on Pediatric Metabolic Disorders:
    An emerging focus on metabolic disorders in pediatric populations, including obesity and type 2 diabetes, is being recognized for its long-term health implications.
  7. Impact of COVID-19 on Metabolic Health:
    Research examining the impact of COVID-19 on metabolic health, including the exacerbation of existing conditions and the emergence of new metabolic disorders post-infection, is increasingly relevant.

Declining or Waning

While the journal maintains a robust focus on various aspects of metabolism and its clinical implications, certain themes have shown a decline in prominence over recent years. This reflects the evolving nature of research in metabolic diseases and changing interests within the scientific community.
  1. Traditional Dietary Approaches:
    Research focusing solely on traditional dietary interventions for metabolic diseases has decreased, as newer, more innovative approaches and pharmacological treatments gain attention.
  2. Basic Biochemical Mechanisms:
    There appears to be a waning interest in purely biochemical studies that do not translate into clinical applications or therapeutic strategies, as the emphasis shifts towards translational research.
  3. Single-Factor Studies:
    Studies investigating the impact of isolated factors on metabolic health without considering the multifactorial nature of metabolic disorders are becoming less frequent, with a growing preference for integrative and systems biology approaches.
  4. Epidemiological Studies without Clinical Correlation:
    While epidemiological studies remain important, there is a noticeable decline in studies that do not connect findings to clinical outcomes or implications, as the journal prioritizes research with direct clinical relevance.

Similar Journals

CLINICAL ENDOCRINOLOGY

Elevating clinical practice through cutting-edge research.
Publisher: WILEYISSN: 0300-0664Frequency: 12 issues/year

CLINICAL ENDOCRINOLOGY, published by Wiley, is a premier journal in the field of endocrinology, providing a vital platform for the dissemination of cutting-edge research and advancements in the diagnosis and treatment of endocrine disorders. Since its inception in 1972, this prestigious journal has maintained its commitment to excellence with its scope encompassing diverse areas within endocrinology, diabetes, and metabolism, evidenced by its impressive ranking in the Q2 quartile for these categories as of 2023. With a growing impact factor, it serves as a leading reference for researchers and healthcare professionals dedicated to improving patient outcomes. Although the journal does not currently offer open access, it remains accessible through institutional subscriptions, ensuring that vital research reaches an expansive audience. Its robust focus on clinical applications makes CLINICAL ENDOCRINOLOGY an essential resource for anyone involved in the evolving field of endocrinology, thereby underscoring its importance in shaping future research and practice in healthcare.

Molecular Metabolism

Connecting Research to Real-World Health Implications
Publisher: ELSEVIERISSN: 2212-8778Frequency: 12 issues/year

Molecular Metabolism is a premier, open-access journal published by Elsevier, dedicated to advancing the understanding of metabolic processes at the molecular level. With an ISSN of 2212-8778 and a proud presence in Germany, the journal has made significant contributions to the fields of Cell Biology and Molecular Biology, consistently achieving a Q1 ranking in both categories as of 2023. The journal’s scope encompasses cutting-edge research that explores metabolic pathways, their regulation, and implications for human health, underscoring the interplay between metabolism and various biological functions. Researchers and professionals benefit from the journal’s robust visibility, as it ranks #40 among 410 journals in Molecular Biology and #35 among 285 in Cell Biology according to Scopus metrics, placing it in the top 10 percentile in its field. With open access since 2012, Molecular Metabolism ensures that groundbreaking research is available to all, fostering a collaborative and inclusive academic environment. Its commitment to excellence and accessibility makes it an invaluable resource for those invested in metabolic research.

TRENDS IN ENDOCRINOLOGY AND METABOLISM

Innovative insights for a healthier tomorrow.
Publisher: CELL PRESSISSN: 1043-2760Frequency: 12 issues/year

TRENDS IN ENDOCRINOLOGY AND METABOLISM, published by CELL PRESS, stands as a pivotal resource in the fields of endocrinology, diabetes, and metabolism. With its ISSN 1043-2760 and E-ISSN 1879-3061, this esteemed journal has been a leading platform since its inception in 1989, currently projected to span until 2024. Recognized within the top quartile (Q1) of its category, it boasts impressive Scopus rankings, holding the 4th position in Endocrinology and 8th in Endocrinology, Diabetes, and Metabolism. These rankings underscore its significant impact, evidenced by an impressive percentile rank of 97th and 96th respectively. The journal is committed to facilitating the dissemination of cutting-edge research and innovative insights, making it an essential read for researchers, clinicians, and students seeking to stay informed on the latest advancements in these critical fields. With a robust focus on providing thorough reviews and original research articles, TRENDS IN ENDOCRINOLOGY AND METABOLISM continues to shape the understanding and treatment of metabolic disorders.

Current Obesity Reports

Empowering solutions for a healthier tomorrow.
Publisher: SPRINGERISSN: 2162-4968Frequency: 4 issues/year

Current Obesity Reports, an esteemed journal published by SPRINGER, serves as a pivotal platform for scholars and practitioners in the field of obesity research. With its ISSN of 2162-4968, this journal has been recognized within the competitive landscape of Medicine & Internal Medicine, achieving a commendable Scopus rank of #11 out of 167, placing it in the top 93rd percentile. Launched in 2012 and covering critical developments in obesity up to 2024, this journal synthesizes innovative research, evidence-based practices, and comprehensive reviews that cater to a diverse audience, from researchers to public health professionals. While currently not offering open access options, it remains dedicated to advancing knowledge and fostering discussions that address the multifaceted issues related to obesity, its public health implications, and treatment methodologies. For those involved in tackling obesity challenges, Current Obesity Reports stands as a vital resource, contributing significantly to the discourse and scholarship in the field.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Navigating the complexities of endocrine and metabolic health.
Publisher: SPRINGERISSN: 1389-9155Frequency: 6 issues/year

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, published by Springer, is a leading journal in the field of endocrinology, diabetes, and metabolism, with an impressive Q1 ranking in both categories as of 2023. With an ISSN of 1389-9155 and E-ISSN 1573-2606, this journal serves as a vital resource for researchers, clinicians, and students seeking comprehensive reviews that address the latest advancements and interdisciplinary approaches in the management of endocrine and metabolic disorders. Operating from the Netherlands, it features articles that are rigorously peer-reviewed and is notable for its significant impact factor reflected in its Scopus rankings, placing it in the top percentile of its categories. Although it does not currently offer open access, it provides critical insights applicable to both basic and clinical settings, making it indispensable for those dedicated to enhancing patient outcomes in endocrine health.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

Exploring Breakthroughs in Endocrinology and Metabolism
Publisher: WALTER DE GRUYTER GMBHISSN: 0334-018XFrequency: 12 issues/year

The JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, published by Walter de Gruyter GmbH, is a reputable peer-reviewed journal dedicated to advancing the field of pediatric endocrinology and metabolism. Since its inception in 1985, this journal has become a vital resource for professionals and researchers, providing insights into the latest advancements, clinical practices, and foundational research in the care of children with endocrine disorders. With a noted Q3 ranking in Endocrinology, Diabetes and Metabolism, and a robust focus on Pediatrics, Perinatology, and Child Health, it addresses important topics such as hormonal imbalances and metabolic syndromes in young populations. Despite its non-open access status, it continues to play an essential role in bridging the knowledge gap within our understanding of children's health and disease, contributing significantly to the progress in this specialized field.

BMC Endocrine Disorders

Championing open access to vital endocrine research.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Endocrine Disorders is a leading open-access journal dedicated to advancing the field of endocrinology, diabetes, and metabolism. Published by BMC since 2001, this journal provides a vibrant platform for researchers to disseminate their findings across a wide array of topics related to endocrine health and disorders. With an impressive Q2 category ranking in both Endocrinology, Diabetes and Metabolism, and Medicine (miscellaneous) for 2023, it has positioned itself among the top-tier journals in its field, reflecting its commitment to high-quality research and discussions. The journal's accessibility enhances its reach and impact, ensuring that important findings are available to all stakeholders in the medical community. Researchers, healthcare professionals, and students alike will find valuable insights and updates that are crucial for both academic and practical applications within this dynamic field. The journal is actively welcoming submissions through 2024, facilitating continuous growth in the scientific discourse surrounding endocrine disorders.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Unveiling the Future of Endocrine Research and Practice
Publisher: ENDOCRINE SOCISSN: 0021-972XFrequency: 12 issues/year

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, published by the Endocrine Society, stands as a premier academic journal within the field of endocrinology, diabetes, and metabolism. With a legacy spanning from 1941 to 2024, this journal is distinguished by its significant impact factor, ranking in the Q1 category across multiple related disciplines including biochemistry, clinical biochemistry, and medicine. This esteemed journal, ISSN 0021-972X and E-ISSN 1945-7197, is backed by rigorous peer review, ensuring the publication of high-quality research that contributes to the advancement of clinical practices and scientific knowledge. With a commendable Scopus ranking, positioned in the top percentile of multiple categories, JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM serves as an essential resource for researchers, professionals, and students who seek to stay informed about the latest findings and innovations in endocrine research. The journal enriches the existing body of knowledge and fosters discussion among scholars and practitioners alike, solidifying its crucial role in the ongoing discourse in endocrinology and metabolic health.

Therapeutic Advances in Endocrinology and Metabolism

Unlocking innovative therapies for metabolic challenges.
Publisher: SAGE PUBLICATIONS LTDISSN: 2042-0188Frequency: 1 issue/year

Therapeutic Advances in Endocrinology and Metabolism is a premier open-access journal published by SAGE Publications Ltd that has established itself as a leading platform for research in the field of endocrinology, diabetes, and metabolism. With a commitment to disseminating high-quality research, the journal aims to advance our understanding of therapeutic interventions and innovations in the management of endocrine disorders. Since its inception in 2010, it has garnered a strong reputation, attaining a Q1 quartile ranking in 2023 in its category and boasting a respectable Scopus rank of #53 out of 244, positioning it within the 78th percentile. As an open-access journal since 2019, Therapeutic Advances in Endocrinology and Metabolism ensures that valuable research findings are accessible to a global audience, fostering collaboration and knowledge sharing among researchers, clinicians, and students alike. The journal's multifaceted objectives encompass the publication of original research, reviews, and clinical studies that contribute to the evolving dialogue surrounding endocrine health. By delivering timely and robust content, it serves as an indispensable resource for those striving to make significant contributions to this vital area of medical science.

ENDOCRINE JOURNAL

Advancing knowledge in endocrinology and metabolism.
Publisher: JAPAN ENDOCRINE SOCISSN: 0918-8959Frequency: 12 issues/year

ENDOCRINE JOURNAL, published by the Japan Endocrine Society, is a pivotal resource for researchers and professionals in the field of endocrinology, diabetes, and metabolism. With a long history dating back to 1954, this journal encompasses a comprehensive range of topics including hormonal regulation, pathophysiology of endocrine diseases, and innovative therapeutic approaches. Despite its classification as open access, the journal remains a beacon of knowledge, with impressive rankings—Q2 in Endocrinology, Diabetes and Metabolism and Q3 in Endocrinology for 2023—ensuring it is a respected source in the academic community. It serves as a critical platform for the dissemination of cutting-edge research, encouraging collaboration and facilitating advancements in understanding complex endocrine disorders. By subscribing to this journal, researchers and students gain access to seminal studies, clinical insights, and a wealth of information that drives this vital field forward.